Skip to main content
708-438-5624 Book Online

Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis in Women.

Healthcare for Women, LLC Blog Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis in Women.
Bacterial Vaginosis

Finally, a study that confirms what many OB/GYNs have suspected all along,  was published in the NEJM on March 6, 2025.  

This study found that when male partners of women with recurrent Bacterial Vaginosis (BV) were treated with a combination of two drugs, the recurrence rate of BV was halved in Women.  Treating both partners simultaneously could reduce the chance of reinfection and lead to better long-term outcomes for women. 

This approach of treating both partners is a paradigm shift when it comes to managing recurrent BV in Women.  The Bottom Line 2025 (Evidence) For recurrent BV in womne with a stable male partner, concomitant treatemet of the male partner with oral metronidazole + Topical clindamycin for 7 days alongside standard female therapy, significantly reduces BV recurrence copared the treating the woman alone. NEJM March 6 2025

 

Author
Lyndon Taylor MD Lyndon Taylor MD OB/GYN in practice for 44 years from Oak Park, Illinois

You Might Also Enjoy...

Telehealth: The Advantages of Telemedicine
Struggles to get to the clinic? Trying to reduce your exposure to COVID-19, as well as other contagious illnesses, and still need to see your doctor? Telehealth is safe and easy — receive quality care from anywhere.
SHIELD - FDA Approved

New Blood Test Screens for Colon Cancer - No S#!T
Shield is an FDA approved Blood Test to screen for Colon Cancer if you are 45 or older. It is approved and covered by Medicare. It detects cell-free DNA in the blood released by Colon Cancer. Colonoscopy is still the Gold Standard for Screening.

Screening for Syphilis during pregnancy
Untreated syphilis infection during pregnancy can be passed to the fetus, causing congenital syphilis. Congenital syphilis is associated with premature birth, low birth weight, stillbirth, neonatal death, and significant abnormalities in the infant.